Incidence and clinicopathologic features of primary lung cancer: A North-Eastern Anatolia region study in Turkey(2006-2012)

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 3, 2013, Pages 1989-1993

  Demirci, Elif ^a   Daloglu, Ferah ^a   Gundogdu, Cemal ^a   Calik, Muhammet ^a   Sipal, Sare ^a   Akgun, Metin ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Histopathology; Incidence data; Lung cancer; Smoking

Indexed keywords

EID: 84880410538     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.3.1989     Document Type: Article

References (27)

1. Alpar S, Uçar N, Aǧaçkiran Y, et al (2004). Akciǧer kanşerlerinin histopatolojik ve morfolojik özellikleri ile bronşiyal yerleşimleri arasindaki ilişkinin deǧerlendirilmesi. Solunum Hastaliklari, 15, 127-31
2. Araz O, Akgün M, Görgüner M (2010). Lung Cancer Incidence in Erzurum City. EAJM, 42, 111-5
3. Arinç S, Ertugrul M, Saltürk C, et al (2007) Primer akciger kanserinde bronkoskopi bulgularinin sigara aliskanligi ile iliskisi. Toraks Dergisi, 8, 6-9.
4. Atici AG, Erkan L, Findik S, Uzun O, Kandemir B (2004). Küçük hücreli disi akciger kanserli hastalarin klinik özellikleri. Tüberküloz ve Toraks Dergisi, 52, 150-8.
5. Bozkurt B, Selçuk ZT, Firat P, Kalyoncu AF, Artvinli M (2004). 1972-2002 döneminde Hacettepe Üniversitesi Tip Fakültesi Hastanesi'nde akciger kanseri tanisi konulan hastalarin histolojik ve epidemiyolojik degerlendirmesi. Toraks Dergisi, 5, 148-53.
6. Bryant A, Cerfolio RJ (2007). Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest, 132, 185-92.
7. Charloux A, Quoix E, Wolkove N, et al (1997). The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol, 26, 14-23.
8. Cox JD, Yesner RA (1979). Adenocarcinoma of the lung: recent results from the veterans administration lung group. Am Rev Respir Dis, 120, 1025-9.
9. De Geer A, Eriksson J, Finnern HW (2013). A cross- country review of data collected on non- small cell lung cancer (NSCLC) patients in cancer registeries, databases, retrospective and non-randomized prospective studies. J Med Economics, 16, 134-49.
10. Dey A, Biswas D, Saha SK, Kundu S, Sengupa A (2012). Comparison study of clinicoradiological profile of primary lung cancer cases: An Eastern India experience. Indian J Cancer, 49, 89-95.
11. Günbatar H, Sertogullarindan B, Özbay B, Sünnetçioglu A, Ekin S (2012). Akciger kanserli olgularin degerlendirilmesi; 3 yillik analiz. Van Tip Dergisi, 19, 13-20.
12. Hsu CL, Chen KY, Shih JY, et al (2012). Advanced non-small lung cancer in patients aged 45 years or younger: outcomes and prognostic factors. BMC Cancer, 12, 241.
13. Itil O (2000). Akciger kanserlerinin epidemiyolojisi ve etyolojisi In: 'Akciger kanserleri: Tani ve tedavi', Ed Haydaroglu A. EgeUniversitesi Basimevi, Izmir pp 15-34.
14. Kanematsu T, Hanibuchi M, Tomimoto H, et al (2010). Epidemiological and clinical features of lung cancer patients from 1999 to 2009 in Tokushima Prefecture of Japan. J Med Investigation, 57, 327-33.
15. Missaoui1N, Hmissal S, Landolsi1 H et al (2011). Lung Cancer in Central Tunisia: Epidemiology and Clinicopathological Features. Asian Pac J Cancer Prev, 12, 2305-9.
16. Navani N, Brown J M, Nankivell M, et al (2012). Suitability of EBUS- TBNA specimens for subtyping and genotyping of NSCLC: a multi-center study of 774 patients. Am J Respir Crit Care Med, 185, 1316-22.
17. Parkin DM, Muir CS (1992). Cancer Incidence in Five Continents. IARC Scientific Publication No.120. Lyon: IARC. pp 45-173.
18. Salim EI, Jazieh AR, Moore MA (2011). Lung cancer incidence in the Arab League countries: risk factors and control. Asian Pac J Cancer Prev, 12, 17-34.
19. Santos-Martines MJ, Curull V, Blanco ML et al (2005). Lung cancer at a universiy hospital: epidemiological and histological characteristics of a recent and a historical series. Arch Bronconeumol, 41, 307-12.
20. Simonato L, Agudo A, Ahrens W, et al (2001). Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer, 91, 876-87.
21. Tacha D, Yu C, Bremer R, Oi W, Haas T (2012). A 6-antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma. Appl Immunohistochem Mol Morphol, 20, 201-7.
22. Thun MJ, Lally CA, Flannery JT et al (1997). Cigarette smoking and changes in the hispathology of lung cancer. J Natl Cancer Inst, 89, 1580-6.
23. Travis WD, Brambilla E, Noguchi M, et al (2011). International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol, 6, 244-85.
24. Travis WD, Travis LB, Devesa SS (1995). Lung cancer. Cancer, 75, 191-202.
25. Turner B, Cagle P, Sainz I, et al (2012). Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and pecific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma:evaluation of 1674 cases by tissue microarray. Arch Pathol Lab Med, 136, 163-71.
26. WHO (1997). Tobacco or health: a global status report. Geneva, Switzerland: world health organization.
27. Yurdakul AS, Çalişir HC, Demiraǧ F, Taci N, Öǧretensoy (2002). Akciǧer kanserinin histolojik tiplerinin daǧilimi; 2216 olgunun analizi. Toraks Dergisi, 1, 59-65.